Election of Board of Directors Appoint Deloitte LLP as Auditor Appointment of Officers Issuance of Stock Options Entering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or...
BCC Announces Initial US$10 Million Drawdown on Credit Facility Resignation of Director TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF)...
BCC Announces Annual Meeting Details Refresh Board of Directors Appoint Deloitte LLP as Auditors Name Change to MPX Bioceutical Corporation TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) — The Canadian...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market Acquiring award-winning wholesale cannabis business in Las Vegas, Nevada TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) — The Canadian...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This...
BCC Reports Q1 Fiscal 2018 Results TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the...
The New West Summit, which will move to a larger venue in Oakland after two initial events in San Francisco, has rapidly established itself as a leading venue for cannabis...
BCC Reports Q4 and Fiscal 2017 Results TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results...
BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and,...
BCC and MJardin Enter into Strategic Partnership for U.S. Cannabis Expansion Partnership to expand operational capacity and grow profit margins TORONTO and DENVER, Aug. 10, 2017 (GLOBE NEWSWIRE) — The...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order TORONTO, Aug. 09, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further...
Civilized continued its excellent “C-Suite” series of interviews with leading cannabis industry executives, interviewing Scott Boyes, CEO of The Canadian Bioceutical Corporation (CSE: BCC) (OTC: CBICF), which is rapidly...
With the exception of Aphria (TSX: APH) (OTC: APHQF), which has involvement with medical cannabis operations in Arizona and Florida, and CanniMed (TSX: CMED) (OTC: CMMDF), which is pursuing...
BCC Completes Massachusetts Transaction Supporting cultivation, production and up to three dispensaries, positioning company well for high anticipated demand in adult use state TORONTO, Ontario, June 15, 2017 (GLOBE...
BCC to Expand U.S. Footprint With Arizona and Maryland Acquisitions Accretive Arizona Target Entry into early-stage, populous Maryland market TORONTO, May 17, 2017 (GLOBE NEWSWIRE) — (CSE: BCC) (OTC:...
BCC expands into second adult use market Acquiring award winning wholesale cannabis business in Las Vegas, Nevada TORONTO, May 04, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the...
BCC to Acquire Massachusetts Cannabis Assets Early Mover Advantage in Legalized Adult Use Market First $9.5M Tranche of Private Placement Closed Conference Call to Discuss New Acquisition on April...
BCC Announces $20 Million Private Placement of Common Shares TORONTO, ON / ACCESSWIRE / March 30, 2017 / The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE: BCC, OTC:...
BCC Completes Acquisition of New Cannabis Assets Company Expands Arizona Footprint – to Establish Third Dispensary Under H4L Brand TORONTO, ON / ACCESSWIRE / March 14, 2017 / The...
We wrote last week about The Canadian Bioceutical Corporation (CSE: BCC) (OTC: CBICF) acquiring Arizona cannabis operations and an option to acquire a Nevada licensed cultivator for $25mm USD, with $15mm...
In yet another example of publicly-traded Canadian companies entering the U.S. cannabis industry, Canadian Bioceuticals (CSE: BCC) (OTC: CBICF), through its CGX Life Sciences subsidiary, announced today the acquisition...
